Related Experiment Video
Updated: Apr 27, 2026

Point-of-Care Lung Ultrasound in Adults: Image Acquisition
Published on: March 3, 2023
IgG4-related pleural disease presenting as a massive bilateral effusion
Atsuko Ishida1, Naoki Furuya, Takashi Nishisaka
1*Department of Internal Medicine, Division of Respiratory and Infectious Diseases, St Marianna University School of Medicine, Kawasaki †Department of Pathology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
This case study identifies IgG4-related disease as a cause of pleural effusion. It highlights the importance of considering IgG4-related disease in unexplained pleuritis diagnoses.
Area of Science:
- Immunology
- Pulmonology
- Pathology
Background:
- Pleural effusion is a common clinical problem with diverse etiologies.
- Immunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory condition that can affect various organs.
Observation:
- A 74-year-old woman presented with massive, exudative pleural effusion and mononuclear cell predominance.
- Parietal pleura showed thickening and reddish discoloration, with biopsy revealing lymphoplasmacytic inflammation and fibrosis.
Findings:
- Immunohistochemical staining of pleural biopsy demonstrated 91 IgG4-positive plasma cells/high-power field and an IgG4/IgG ratio of 91%.
- These findings confirmed the diagnosis of pleuritis secondary to IgG4-related disease.
Implications:
- This case suggests IgG4-related disease should be considered in the differential diagnosis of unexplained pleural effusions.
- Early recognition and diagnosis of IgG4-related pleuritis can guide appropriate management strategies.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Pulmonary Edema II: Pathophysiology
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumothorax II: Pathophysiology

